Computational Ways to Enhance Protein Inhibitor Design

Two new computational approaches are described to aid in the design of new peptide-based drugs by evaluating ensembles of protein structures from their dynamics and through the assessing of structures using empirical contact potential. These approaches build on the concept that conformational variab...

Full description

Bibliographic Details
Main Authors: Robert L. Jernigan, Kannan Sankar, Kejue Jia, Eshel Faraggi, Andrzej Kloczkowski
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-02-01
Series:Frontiers in Molecular Biosciences
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmolb.2020.607323/full
id doaj-e05ebc98a09941ddb58e2d5aacba8431
record_format Article
spelling doaj-e05ebc98a09941ddb58e2d5aacba84312021-02-03T04:43:35ZengFrontiers Media S.A.Frontiers in Molecular Biosciences2296-889X2021-02-01710.3389/fmolb.2020.607323607323Computational Ways to Enhance Protein Inhibitor DesignRobert L. Jernigan0Kannan Sankar1Kejue Jia2Eshel Faraggi3Eshel Faraggi4Andrzej Kloczkowski5Andrzej Kloczkowski6Roy J. Carver Department of Biochemistry, Biophysics and Molecular Biology, Iowa State University, Ames, IA, United StatesRoy J. Carver Department of Biochemistry, Biophysics and Molecular Biology, Iowa State University, Ames, IA, United StatesRoy J. Carver Department of Biochemistry, Biophysics and Molecular Biology, Iowa State University, Ames, IA, United StatesResearch and Information Systems, LLC, Indianapolis, IN, United StatesDepartment of Physics, Indiana University Purdue University Indianapolis, Indianapolis, IN, United StatesBattelle Center for Mathematical Medicine, Nationwide Children's Hospital, Columbus, OH, United StatesDepartment of Pediatrics, The Ohio State University, Columbus, OH, United StatesTwo new computational approaches are described to aid in the design of new peptide-based drugs by evaluating ensembles of protein structures from their dynamics and through the assessing of structures using empirical contact potential. These approaches build on the concept that conformational variability can aid in the binding process and, for disordered proteins, can even facilitate the binding of more diverse ligands. This latter consideration indicates that such a design process should be less restrictive so that multiple inhibitors might be effective. The example chosen here focuses on proteins/peptides that bind to hemagglutinin (HA) to block the large-scale conformational change for activation. Variability in the conformations is considered from sets of experimental structures, or as an alternative, from their simple computed dynamics; the set of designe peptides/small proteins from the David Baker lab designed to bind to hemagglutinin, is the large set considered and is assessed with the new empirical contact potentials.https://www.frontiersin.org/articles/10.3389/fmolb.2020.607323/fullprotein designpeptide designcomputational designprotein ensembleprotein potentials
collection DOAJ
language English
format Article
sources DOAJ
author Robert L. Jernigan
Kannan Sankar
Kejue Jia
Eshel Faraggi
Eshel Faraggi
Andrzej Kloczkowski
Andrzej Kloczkowski
spellingShingle Robert L. Jernigan
Kannan Sankar
Kejue Jia
Eshel Faraggi
Eshel Faraggi
Andrzej Kloczkowski
Andrzej Kloczkowski
Computational Ways to Enhance Protein Inhibitor Design
Frontiers in Molecular Biosciences
protein design
peptide design
computational design
protein ensemble
protein potentials
author_facet Robert L. Jernigan
Kannan Sankar
Kejue Jia
Eshel Faraggi
Eshel Faraggi
Andrzej Kloczkowski
Andrzej Kloczkowski
author_sort Robert L. Jernigan
title Computational Ways to Enhance Protein Inhibitor Design
title_short Computational Ways to Enhance Protein Inhibitor Design
title_full Computational Ways to Enhance Protein Inhibitor Design
title_fullStr Computational Ways to Enhance Protein Inhibitor Design
title_full_unstemmed Computational Ways to Enhance Protein Inhibitor Design
title_sort computational ways to enhance protein inhibitor design
publisher Frontiers Media S.A.
series Frontiers in Molecular Biosciences
issn 2296-889X
publishDate 2021-02-01
description Two new computational approaches are described to aid in the design of new peptide-based drugs by evaluating ensembles of protein structures from their dynamics and through the assessing of structures using empirical contact potential. These approaches build on the concept that conformational variability can aid in the binding process and, for disordered proteins, can even facilitate the binding of more diverse ligands. This latter consideration indicates that such a design process should be less restrictive so that multiple inhibitors might be effective. The example chosen here focuses on proteins/peptides that bind to hemagglutinin (HA) to block the large-scale conformational change for activation. Variability in the conformations is considered from sets of experimental structures, or as an alternative, from their simple computed dynamics; the set of designe peptides/small proteins from the David Baker lab designed to bind to hemagglutinin, is the large set considered and is assessed with the new empirical contact potentials.
topic protein design
peptide design
computational design
protein ensemble
protein potentials
url https://www.frontiersin.org/articles/10.3389/fmolb.2020.607323/full
work_keys_str_mv AT robertljernigan computationalwaystoenhanceproteininhibitordesign
AT kannansankar computationalwaystoenhanceproteininhibitordesign
AT kejuejia computationalwaystoenhanceproteininhibitordesign
AT eshelfaraggi computationalwaystoenhanceproteininhibitordesign
AT eshelfaraggi computationalwaystoenhanceproteininhibitordesign
AT andrzejkloczkowski computationalwaystoenhanceproteininhibitordesign
AT andrzejkloczkowski computationalwaystoenhanceproteininhibitordesign
_version_ 1724289459857391616